Effects of perioperative administration of Calcium dibutyryladenosine cyclophosphate on myocardial protection in patients undergoing coronary artery bypass grafting
10.3760/cma.j.issn.1673-4904.2019.11.010
- VernacularTitle: 围手术期使用二丁酰环磷腺苷钙对冠状动脉搭桥术患者的心肌保护作用
- Author:
Ming LI
1
;
Suochun XU
1
;
Yang YAN
1
;
Haichen WANG
1
;
Yongxin LI
1
;
Qiuyue YI
1
;
Yongjian ZHANG
1
;
Junjun HAO
1
;
Chao DENG
1
;
Li XUE
2
Author Information
1. Department of Cardiovascular Surgery, the First Affiliated Hospital of Medical College of Xi′an Jiaotong University, Xi′an 710061, China
2. Department of Clinical Laboratory, the Second Affiliated Hospital of Medical College of Xi′an Jiaotong University, Xi′an 710004, China
- Publication Type:Journal Article
- Keywords:
Coronary disease;
Perioperative period;
Calcium dibutyryladenosine cyclophosphate;
Myocardial protection
- From:
Chinese Journal of Postgraduates of Medicine
2019;42(11):1006-1009
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effect of Calcium dibutyryladenosine cyclophosphate on myocardial ischemia-reperfusion injury in patients undergoing coronary artery bypass grafting (CABG) operation.
Methods:The clinical data of 62cases were retrospectively analyzed. These patients were performed coronary artery bypass graft (CABG) operation under cardiopulmonary bypass (CPB) in the First Affiliated Hospital of Medical College of Xi′an Jiaotong University from January 2013 to January 2016. According to the use calcium dibutyryladenosine cyclophosphate, 62 patients were divided into the control group and the experimental group. Thirty-one cases in the experimental group were given an intravenous drip of calcium dibutyryladenosine cyclophosphate, while other 31 cases in the control group were not given to calcium dibutyryladenosine cyclophosphate during perioperative period. Venous blood was collected from each patient 1 h before the surgery and 2, 6, 24 and 72 h after unclamping the aorta, then serum levels of aspartate aminotransferase (AST), lactic acid dehydrogenase (LDH), creatine kinase (CK), and creatine kinase-MB isozyme (CK-MB) were detected. Additionally, cardiac function indices including SV, LVDD, CO, LVEF in these patients were recorded before the operation and 6 days after operation.
Results:Compared with those before the operation, the levels of serum enzymes were all significantly increased after unclamping the aorta. The levels of serum AST, LDH and CK reached their peak 24 h after unclamping the aorta. Notably, the levels of serum AST, LDH and CK in the experimental group were lower than those in the control group at each time point after unclamping the aorta (P < 0.05). For serum CK-MB, the level in both the two groups reached its peak 6 h after unclamping the aorta. The level of CK-MB in the experimental group was significantly decreased compared with that in the control group 6, 24 and 72 h after unclamping the aorta (P < 0.05). Moreover, there were no significant differences in cardiac function indices between the 2 groups before the operation (P > 0.05). The levels of SV, CO and LVEF in the experimental group were significantly increased while the level of LVDD was obviously decreased compared to that in the control group after the operation, SV: (70.93 ± 9.72) ml vs. (65.07 ± 6.81) ml, CO: (5.32 ± 0.98) L vs. (4.29 ± 0.91) L, LVEF: (57.87 ± 8.92)% vs. (52.68 ± 7.31)% and LVDD: (55.67 ± 4.12) mm vs. (62.85 ± 5.71) mm, and there were statistical differences (P < 0.05).
Conclusions:Calcium dibutyryladenosine cyclophosphate has protective effects on myocardial ischemia-reperfusion injury and cardiac function in patients undergoing CABG operation under CPB, by reducing serum levels of myocardial enzymes in these patients.
